Trochanteric pain, also known as trochanteric bursitis or pseudotrochanteric bursitis
Conditions
Interventions
1. Intervention group: Usual care combined with corticosteroid injections (triamcenalonacetaat 40 mg, lidocaine 1%)
2. Control group: Usual care.
Sponsors
Erasmus Medical Center, Department of General Practice
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18 till 80 consulting the general practitioner with trochanteric hip pain existing longer then one week, with the following signs: 1. Severe local pain by pressure at the trochanter major, but unsure whether the patient recognizes this as the pain he/she consulted for; 2. Local pain by pressure at the trochanter major, which thepatient recognizes as the pain he/she consulted for.
Exclusion criteria
Exclusion criteria: 1. Patients who don’t understand the questionnaires because of inadequate mastering of Dutch language or cognitive disorders; 2. Patients who presented themselves in the previous year to the GP with the same complaints; 3. Patients with sensibility disorders due to meralgia paresthetica, patients who previously have undergone hip surgery at the same side and patients with systematic rheumatologic or neurologic disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Experienced recovery (7 points Likert scale) and severity of pain (0-10 VAS) at 3 months follow up. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Disease specific outcomes of pain and function (WOMAC/HOOS), at 3 and 12 months follow up; 2. Primary outcomes at 6 weeks and at 6, 9 and 12 months follow-up; 3. Cost effectiveness over 12 months of follow-up. Costs will be estimated by medical consumption, and productivity loss (PRODISC). | — |
Contacts
Public ContactS. Bierma-Zeinstra
Erasmus Medical Center, Department of General Practice, P.O. Box 1738
Outcome results
None listed